This article summarized the latest R&D progress of methscopolamine bromide, the Mechanism of Action for methscopolamine bromide, and the drug target R&D trends for methscopolamine bromide.
This article summarized the latest R&D progress of methsuximide, the Mechanism of Action for methsuximide, and the drug target R&D trends for methsuximide.
Despite Novartis being a consistent top contender in the pharmaceutical sector in terms of revenue, its growth and market value in recent years has been rather dismal.
Androgen receptor (AR) is a type of nuclear receptor that is activated by binding of either of the androgenic hormones testosterone or dihydrotestosterone in the cytoplasm and then translocating into the nucleus.
In conjunction with Zealand Pharma A/S, Boehringer Ingelheim has initiated three Phase III research investigations for survodutide (also known as BI 456906)
This article summarized the latest R&D progress of methyclothiazide, the Mechanism of Action for methyclothiazide, and the drug target R&D trends for methyclothiazide.
This article summarized the latest R&D progress of ingenol mebutate, the Mechanism of Action for ingenol mebutate, and the drug target R&D trends for ingenol mebutate.